KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial.

Nat Commun · 2025-Jul-21 · PMID 40691143

Panel I质量警告待 EXE 对齐验证

Progression Free Survival

Fig. 3. Pro-inflammatory pathway transcriptionally upregulated in R- vs NR-mesotheliomas. A Box plots showing relative chemokine expression corresponding to CCL5, CCL16, CCL17, CCL19, CCL21 and CCL23 transcripts in R- vs NR-mesotheliomas (* indicates a Wilcoxon signed rank test, two-sided p -value equal to or less than 0.05, ** equal to or less than 0.01). Y -axis units correspond to fragments per kilobase of feature per million mapped reads (TPM) normalised counts. The boxplots show the median line and interquartile range (IQR, 25 th −75 th percentiles), with the whiskers extending to the maximum and minimum values. B Boxplots showing Interleukins IL17C, IL23A and IL24 transcripts in R- vs NR-mesotheliomas. The boxplots show the median line and interquartile range (IQR, 25 th −75 th percentiles), with the whiskers extending to the maximum and minimum values. C Scatter plot showing CCL19 versus B lymphocyte lineage as determined by transcriptome deconvolution. Blue dots correspond to R-mesotheliomas and purple to NR (spearman’s rank correlation coefficient= 0.85, p = 1.1 × 10 −7 ). D Scatter plot showing IL24 versus B lymphocyte lineage as determined by transcriptome deconvolution. Blue dots correspond to R-mesotheliomas and purple to NR (spearman’s rank correlation coefficient= 0.66, two-sided p = 0.0006). E Box plot comparing IL24/EMT ratio in R- vs NR- mesotheliomas (*** indicates a significance p < 0.0001). F Receiver operating characteristics plot for the ratio of IL24 transcript levels to EMT enrichment score in R- vs NR-mesotheliomas. AUROC was 0.9. G Left. Box plot showing the relative enrichment of CD8 immune cells in R (blue) vs NR (purple) mesotheliomas deconvoluted using MCP-Counter, Wilcoxon two-sided p = 0.024). This boxplot shows the median line and interquartile range (IQR, 25 th −75 th percentiles), with the whiskers extending to the maximum and minimum values. Right. Scatter plots showing CD8 + T cell enumeration by deconvolution versus multiplex immunofluorescence (mIF) respectively. Spearman’s r = 0.6018, p = 0.002. H Correlation matrix showing a positive (blue) correlation between immune deconvolution algorithms (CIBERSORT, MCP Counter) and multiplex immunofluorescence for CD8 T cell enumeration. I Kaplan Meier curves showing progression free survival of CD8 T cells, EMT, or IL24/CCL19 ratio (dichotomised by the medians) in an independent (MEDUSA) cohort.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.67
质量通过否
预期曲线3
实际曲线2
X 范围-900 – 6.1e+03
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

匹配 57 行
Curve序号X (norm)Y (norm)X (real)Y (real)X (pixel)Y (pixel)
110.00000.4267-900.00005568
120.07660.4267313.33337668
130.08030.4267406.66677768
140.08390.4267500.00007868
150.08760.4133593.33337969
160.09120.4133686.66678069
170.09490.4133780.00008169
180.09850.4000873.33338270
190.10220.4000966.66678370
1100.10580.40001060.00008470
1110.10950.37331153.33338572
1120.11310.37331246.66678672
1130.11680.37331340.00008772
1140.12040.37331433.33338872
1150.12410.37331526.66678972
1160.12770.37331620.00009072
1170.13140.37331713.33339172
210.00000.3600-900.00005573
220.52190.36006100.000019873
230.52550.36006100.000019973
240.52920.36006100.000020073
250.53280.36006100.000020173
260.53650.36006100.000020273
270.54010.36006100.000020373
280.54380.36006100.000020473
290.54740.36006100.000020573
2100.55110.36006100.000020673
2110.55470.36006100.000020773
2120.55840.36006100.000020873
2130.56200.36006100.000020973
2140.56570.36006100.000021073
2150.56930.36006100.000021173
2160.57300.36006100.000021273
2170.57660.36006100.000021373
2180.58030.36006100.000021473
2190.58390.36006100.000021573
2200.58760.36006100.000021673
2210.59120.36006100.000021773
2220.59490.36006100.000021873
2230.59850.36006100.000021973
2240.60220.36006100.000022073
2250.60580.36006100.000022173
2260.60950.36006100.000022273
2270.61310.36006100.000022373
2280.61680.36006100.000022473
2290.62040.36006100.000022573
2300.62410.36006100.000022673
2310.62770.36006100.000022773
2320.63140.36006100.000022873
2330.63500.36006100.000022973
2340.63870.36006100.000023073
2350.64230.36006100.000023173
2360.64600.36006100.000023273
2370.64960.36006100.000023373
2380.65330.36006100.000023473
2390.65690.36006100.000023573
2400.66060.36006100.000023673
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0quality_warning待验证22026-07-23T17:31:35+00:00